BERMUDEZ HUMARAN; Luis

Patent Applications and Registrations

Patent applications and USPTO patent grants for BERMUDEZ HUMARAN; Luis.The latest application filed is for "new probiotic strain of lactobacillus brevis".

Company Profile

5.3.9

BERMUDEZ HUMARAN; Luis - BIEVRES FR
Bermudez Humaran; Luis - Jouy en Josas FR
Bermudez-Humaran; Luis - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New Probiotic Strain Of Lactobacillus Brevis App 20210268044 - BERMUDEZ HUMARAN; Luis ; et al.	2021-09-02
Faecalibacterium prausnitzii strain CNCM 1-4573 for the treatment and prevention of gastrointestinal inflammation Grant 10,918,678 - Langella , et al. February 16, 2	2021-02-16
Faecalibacterium Prausnitzii Strains For Treating And Preventing Gastrointestinal Pain App 20200316138 - LANGELLA; Philippe ; et al.	2020-10-08
Faecalibacterium Prausnitzii Strains For Treating And Preventing Gastrointestinal Pain App 20190381115 - LANGELLA; Philippe ; et al.	2019-12-19
Lactococcus lactis producing TSLP or IL-25 and their uses as probiotics and therapeutics Grant 10,238,697 - Langella , et al.	2019-03-26
Faecalibacterium Prausnitzii Strain Cncm 1-4573 For The Treatment And Prevention Of Gastrointestinal Inflammation App 20190030089 - Langella; Philippe ; et al.	2019-01-31
Lactococcus Lactis Producing Tslp Or Il-25 And Their Uses As Probiotics And Therapeutics App 20180104285 - LANGELLA; PHILIPPE ; et al.	2018-04-19
Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) Grant 9,688,742 - Vergnolle , et al. June 27, 2	2017-06-27
Stress-regulated Prokaryotic Expression Cassettes App 20150139940 - Bermudez Humaran; Luis ; et al.	2015-05-21
Recombinant Probiotic Bacteria For The Prevention And Treatment Of Inflammatory Bowel Disease (ibd) And Irritable Bowel Syndrome (ibs) App 20150073125 - Vergnolle; Nathalie ; et al.	2015-03-12
Recombinant Probiotic Bacteria For The Prevention And Treatment Of Inflammatory Bowel Disease (ibd) And Irritable Bowel Syndrome (ibs) App 20130344033 - Vergnolle; Nathalie ; et al.	2013-12-26
Recombinant Probiotic Bacteria For The Prevention And Treatment Of Inflammatory Bowel Disease (ibd) And Irritable Bowel Syndrome (ibs) App 20120195859 - VERGNOLLE; Nathalie ; et al.	2012-08-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.